Skip to content

60 Degrees Pharmaceuticals, Inc.

SXTP· NasdaqCore metricsCIK 1946563

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -3.04%
Market cap
$581.57K
1.16M shares
Filings
227
$233.24K
Q3 2026+65.5% FY25 yoy
-$2.56M
Q3 2026N/M FY25 yoy
-$2.53M
Q3 2026N/M FY25 yoy
-$6.45M
Q3 2026derivedN/M FY25 yoy
-$0.75
Q3 2026N/M FY25 yoy
$306.19K
Q3 2026−9.0% FY25 yoy
$581.57K
—
0.6×
0.7×
-1413.80%
—

Twelve months to Sep 30, 2026 · derived

Price

$0.5060.00%$0.75past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$1.01MFY 2025
$1.01M0FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$1,005,471reported
FY 20242024-12-31$607,574reported
FY 20232023-12-31$253,573reported
FY 20222022-12-31$223,208reported

Segments

Products
Revenue by Products, FY2022 to FY2023FY2022Product Revenues – net of Discounts and Rebates · FY2022 · $192.91KService Revenues · FY2022 · $30.30KFY2023Product Revenues – net of Discounts and Rebates · FY2023 · $253.57K
LineFY2023ShareChange
Product Revenues – net of Discounts and Rebates$253.57K100%+31.4%
Service Revenues———
Total$253.57K

From the 10-K filed Apr 1, 2024SXTP

Pharmaceutical preparations

60 Degrees Pharmaceuticals, Inc. is the 215th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

60 Degrees Pharmaceuticals, Inc. · CIK 1946563 · Engraved from SEC EDGAR